Tranexamic Acid administered after Traumatic Brain Injury may reduce mortality
Traumatic Brain Injury (TBI) is a devastating condition with limited venues of pharmacological treatment that would improve outcomes. A new trial published in the Lancet  shows evidence of improved outcomes in TBI using Tranexamic acid.
This study was a international multicenter randomized placebo-controlled trial of Tranexamic acid administered within 3 hours of injury which included 12737 patients with TBI with a GCS of 12 or lower or any intracranial bleeding on CT scan.
Please continue here.